Clinical Trials Directory

Trials / Completed

CompletedNCT06560892

Comparison of Intraperitoneal Bupivacaine Alone or With Dexmedetomidine

Comparison Between Mean Duration of Post-operative Analgesia of Intraperitoneal Bupivacaine Alone or With Dexmedetomidine Following Laparoscopic Cholecystectomy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
68 (actual)
Sponsor
RESnTEC, Institute of Research · Academic / Other
Sex
All
Age
20 Years – 70 Years
Healthy volunteers
Not accepted

Summary

For patients with symptomatic cholelithiasis, laparoscopic cholecystectomy (LC) is a customary procedure for treatment these days. After LC, patients may experience considerable pain. This study was performed with the objective of comparing the mean duration of analgesia of intraperitoneal bupivacaine with dexmedetomidine to intraperitoneal bupivacaine alone in patients undergoing laparoscopic cholecystectomy.

Conditions

Interventions

TypeNameDescription
DRUGBupivacaine injectionpatients received intraperitoneal bupivacaine 50 ml 0.25% + 5 ml normal saline.
DRUGDexmedetomidine injectionPatients were given intraperitoneal bupivacaine 50 ml 0.25% + dexmedetomidine 1 μg/kg with normal saline 5 ml.

Timeline

Start date
2024-01-01
Primary completion
2024-06-30
Completion
2024-06-30
First posted
2024-08-19
Last updated
2024-08-21

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT06560892. Inclusion in this directory is not an endorsement.